|
Mechanism30S subunit inhibitors [+1] |
|
|
Active Indication- |
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCRTH2 antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Kbp Biosciences Holdings Ltd.
0 Patents (Medical) associated with Kbp Biosciences Holdings Ltd.
100 Deals associated with Kbp Biosciences Holdings Ltd.
100 Translational Medicine associated with Kbp Biosciences Holdings Ltd.